肺癌合并慢性阻塞性肺病的不同发生率及病理类(4) -湖南工业职业技术学院学报杂志社投稿

来稿应自觉遵守国家有关著作权法律法规，不得侵犯他人版权或其他权利，如果出现问题作者文责自负，而且本刊将依法追究侵权行为给本刊造成的损失责任。本刊对录用稿有修改、删节权。经本刊通知进行修改的稿件或被采用的稿件，作者必须保证本刊的独立发表权。一、投稿方式： 1、请从我刊官网直接投稿。 2、请从我编辑部编辑的推广链接进入我刊投审稿系统进行投稿。二、稿件著作权： 1、投稿人保证其向我刊所投之作品是其本人或与他人合作创作之成果，或对所投作品拥有合法的著作权，无第三人对其作品提出可成立之权利主张。 2、投稿人保证向我刊所投之稿件，尚未在任何媒体上发表。 3、投稿人保证其作品不含有违反宪法、法律及损害社会公共利益之内容。 4、投稿人向我刊所投之作品不得同时向第三方投送，即不允许一稿多投。 5、投稿人授予我刊享有作品专有使用权的方式包括但不限于：通过网络向公众传播、复制、摘编、表演、播放、展览、发行、摄制电影、电视、录像制品、录制录音制品、制作数字化制品、改编、翻译、注释、编辑，以及出版、许可其他媒体、网站及单位转载、摘编、播放、录制、翻译、注释、编辑、改编、摄制。 6、第5条所述之网络是指通过我刊官网。 7、投稿人委托我刊声明，未经我方许可，任何网站、媒体、组织不得转载、摘编其作品。

肺癌合并慢性阻塞性肺病的不同发生率及病理类(4)

作者:

关键词:

摘要：

[7] The Global Initiative for Chronic Obstructive Lung strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease(2020 report)[R/OL].[2019-12-03].

[8] MOURONTE-ROIBSC,LEIRO-FERNNDEZ V,RUANO-RAVIA A,et obstructive pulmonary disease in lung cancer patients: prevalence, underdiagnosis, and clinical characterization[J].Respiration,2018,95(6):414-421.

[9] DURHAM A L,ADCOCK I M.The relationship between COPD and lung cancer[J].Lung Cancer,2015,90(2):121-127.

[10] YI Y S,BAN W H,SOHNG K Y.Effect of COPD on symptoms, quality of life and prognosis in patients with advanced non-small cell lung cancer[J].BMC Cancer,2018,18(1):1053.

[11] SPYRATOS D,PAPADAKI E,LAMPAKI S,et obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges[J].Lung Cancer,2017, 8:101-107.

[12] HASHIMOTO N,MATSUZAKI A,OKADA Y,et impact of prevalence and severity of COPD on the decision-making process for therapeutic management of lung cancer patients[J].BMC Pulm Med,2014,14(1):14.

[13] NORIHITO O,NAOZUMI H,MASAHIRO M,et of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy[J].Int J Chron Obstruct Pulmon Dis,2017,12:3541-3547.

[14] LIU S,ZHANG M,YANG L,et and patterns of tobacco smoking among Chinese adult men and women: findings of the 2010 national smoking survey[J].J Epidemiol Community Health,2017,71(2):154-161.

[15] ETTINGER D S,WOOD D E,AISNER D L,et cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology[J].J Natl Compr Canc Netw,2017,15(4):504-535.

[16] DE-TORRES J P,WILSON DO,SANCHEZ-SALCEDO P,et al.Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score[J].Am J Respir Crit Care Med,2015,191(3):285-291.

[17] 赵松林,聂秀红,张霖,等.慢性阻塞性肺疾病合并原发性支气管肺癌118例临床特征分析[J].中国肺癌杂志,2017,20(8):538-542.

[18] BOZINOVSKI S,VLAHOS R,ANTHONY D,et al.COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link[J].Br J Pharmacol,2016,173(4):635-648.

[19] KANG H S,SHIN A Y,YEO C D,et al.A lower level of forced expiratory volume in one second predicts the poor prognosis of small cell lung cancer[J].J Thorac Dis,2018,10(4):2179-2185.

[20] STRANDKVIST VJ,BACKMAN H,R?DING J,et al.Hand grip strength is associated with forced expiratory volume in 1 second among subjects with COPD: report from a population-based cohort study[J].Int J Chron Obstruct PulmonDis,2016,11:2527-2534.

[21] MENEZES AM,PéREZ-PADILLA R,WEHRMEISTER FC,et a better predictor of mortality than FVC: the PLATINO cohort study[J].PLoS One,2014,9(10):e.

[22] QIAO WL,SHI BW,HAN YD,et protease 50 as an independent risk factor for poor prognosis in patients with non-small cell lung cancer[J].Oncol Lett,2018,15(6):8796-8804.

[23] WANG W,XIE M,DOU S,et al.The link between chronic obstructive pulmonary disease phenotypes and histological subtypes of lung cancer: a case-control study[J].Int J Chron Obstruct Pulmon Dis,2018,13:1167-1175.

文章来源：《湖南工业职业技术学院学报》网址: http://www.hngyzyjsxyxb.cn/qikandaodu/2021/0708/1198.html